β-淀粉样蛋白与阿尔茨海默病神经网络异常

李 翠1,2,3 , 赵 丽4,* , 臧卫东2,3
1郑州大学体育学院(校本部),郑州 450001 2郑州大学基础医学院,郑州 450001 3郑州大学神经科学研究所,郑州 450001 4北京体育大学运动生理教研室,北京 100084

摘 要:

阿尔茨海默病(Alzheimer’s disease, AD) 是老年人中最常见的神经退行性疾病,临床表现为进行性的认知障碍、行为紊乱及人格改变。β- 淀粉样蛋白(amyloid-β protein, Aβ) 是AD发生发展的关键因素。该文主要从Aβ 诱导的突触功能障碍、突触丢失、神经元兴奋性异常、不同类型神经元丢失、神经网络兴奋/抑制失衡及theta 和gamma 等神经节律异常几个层面综述Aβ 引发神经网络功能障碍的机制,以期为临床药物研究或开发基于神经网络的AD早期诊断的生物标志物提供一定的思路。

通讯作者:赵 丽 , Email:zhaolispring@126.com

Amyloid β-protein and neural network abnormality in Alzheimer’s disease
LI Cui1,2,3 , ZHAO Li4,* , ZANG Wei-Dong2,3
1School of Physical Education (Main Campus), Zhengzhou 450001, China 2School of Basic Medical Sciences, Zhengzhou 450001, China 3Institute of Neuroscience, Zhengzhou University, Zhengzhou 450001, China 4Department of Exercise of Physiology, Beijing Sport University, Beijing 100084, China

Abstract:

Alzheimer’s disease (AD) is the most common neurodegenerative disease in the elderly, with clinical manifestations of progressive cognitive impairment, behavioral disorder, and personality change. Amyloid β-protein (Aβ) is a key factor in the occurrence and development of AD. This article mainly reviews Aβ-induced synaptic dysfunction, synapses loss, abnormal neuron excitability, loss of different types of neurons, neural network excitation/inhibition imbalance, neural oscillations abnormalities, such as theta and gamma oscillations. It is expected to provide some ideas for clinical drug research or the development of neural network-based biomarkers for the early diagnosis of AD.

Communication Author:ZHAO Li , Email:zhaolispring@126.com

Back to top